Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells
Spitzer, Martin S.
, Yoeruek, Efdal, Sierra, Ana, Wallenfels-Thilo, Barbara, Schraermeyer, Ulrich, Spitzer, Bernhard , Bartz-Schmidt, Karl U. and Szurman, Peter
(2007)
Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
Graefe's Archive for Clinical and Experimental Ophthalmology 245 (12), pp. 1837-1842.
Date of publication of this fulltext: 19 Dec 2024 13:34
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Graefe's Archive for Clinical and Experimental Ophthalmology | ||||
| Publisher: | SPRINGER | ||||
|---|---|---|---|---|---|
| Place of Publication: | NEW YORK | ||||
| Volume: | 245 | ||||
| Number of Issue or Book Chapter: | 12 | ||||
| Page Range: | pp. 1837-1842 | ||||
| Date | 2007 | ||||
| Institutions | Human Sciences > Institut für Psychologie | ||||
| Identification Number |
| ||||
| Keywords | ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; DISEASE; bevacizumab (Avastin); pegaptanib (Macugen); ranibizumab (Lucentis); ocular cells; antiproliferative | ||||
| Dewey Decimal Classification | 100 Philosophy & psychology > 150 Psychology | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68656 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric